vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and DT Midstream, Inc. (DTM). Click either name above to swap in a different company.

DT Midstream, Inc. is the larger business by last-quarter revenue ($317.0M vs $205.4M, roughly 1.5× COLLEGIUM PHARMACEUTICAL, INC). DT Midstream, Inc. runs the higher net margin — 35.0% vs 8.3%, a 26.8% gap on every dollar of revenue. On growth, DT Midstream, Inc. posted the faster year-over-year revenue change (27.3% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $30.0M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 14.9%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Oneok, Inc. ONE-oak, stylized as ONEOK, is an American oil and gas midstream operator headquartered in Tulsa, Oklahoma. It provides the oil and gas industry with gathering, processing, fractionation, transportation, and storage services. The company is part of the Fortune 500 and S&P 500. Oneok was founded as Oklahoma Natural Gas Company in 1906, but it changed its corporate name to Oneok in 1980.

COLL vs DTM — Head-to-Head

Bigger by revenue
DTM
DTM
1.5× larger
DTM
$317.0M
$205.4M
COLL
Growing faster (revenue YoY)
DTM
DTM
+14.4% gap
DTM
27.3%
12.9%
COLL
Higher net margin
DTM
DTM
26.8% more per $
DTM
35.0%
8.3%
COLL
More free cash flow
COLL
COLL
$92.4M more FCF
COLL
$122.4M
$30.0M
DTM
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
14.9%
DTM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
COLL
COLL
DTM
DTM
Revenue
$205.4M
$317.0M
Net Profit
$17.0M
$111.0M
Gross Margin
62.5%
Operating Margin
29.6%
49.2%
Net Margin
8.3%
35.0%
Revenue YoY
12.9%
27.3%
Net Profit YoY
35.3%
52.1%
EPS (diluted)
$0.48
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
DTM
DTM
Q4 25
$205.4M
$317.0M
Q3 25
$209.4M
$314.0M
Q2 25
$188.0M
$309.0M
Q1 25
$177.8M
$303.0M
Q4 24
$181.9M
$249.0M
Q3 24
$159.3M
$248.0M
Q2 24
$145.3M
$244.0M
Q1 24
$144.9M
$240.0M
Net Profit
COLL
COLL
DTM
DTM
Q4 25
$17.0M
$111.0M
Q3 25
$31.5M
$115.0M
Q2 25
$12.0M
$107.0M
Q1 25
$2.4M
$108.0M
Q4 24
$12.5M
$73.0M
Q3 24
$9.3M
$88.0M
Q2 24
$19.6M
$96.0M
Q1 24
$27.7M
$97.0M
Gross Margin
COLL
COLL
DTM
DTM
Q4 25
62.5%
Q3 25
61.7%
Q2 25
57.7%
Q1 25
54.8%
Q4 24
54.0%
Q3 24
60.8%
Q2 24
62.5%
Q1 24
63.1%
Operating Margin
COLL
COLL
DTM
DTM
Q4 25
29.6%
49.2%
Q3 25
29.7%
49.4%
Q2 25
18.7%
50.2%
Q1 25
12.2%
48.8%
Q4 24
20.9%
45.4%
Q3 24
21.9%
49.2%
Q2 24
32.7%
53.3%
Q1 24
34.1%
51.7%
Net Margin
COLL
COLL
DTM
DTM
Q4 25
8.3%
35.0%
Q3 25
15.0%
36.6%
Q2 25
6.4%
34.6%
Q1 25
1.4%
35.6%
Q4 24
6.9%
29.3%
Q3 24
5.9%
35.5%
Q2 24
13.5%
39.3%
Q1 24
19.1%
40.4%
EPS (diluted)
COLL
COLL
DTM
DTM
Q4 25
$0.48
$1.07
Q3 25
$0.84
$1.13
Q2 25
$0.34
$1.04
Q1 25
$0.07
$1.06
Q4 24
$0.36
$0.73
Q3 24
$0.27
$0.90
Q2 24
$0.52
$0.98
Q1 24
$0.71
$0.99

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
DTM
DTM
Cash + ST InvestmentsLiquidity on hand
$386.7M
$54.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$4.7B
Total Assets
$1.7B
$10.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
DTM
DTM
Q4 25
$386.7M
$54.0M
Q3 25
$285.9M
$98.0M
Q2 25
$222.2M
$74.0M
Q1 25
$197.8M
$83.0M
Q4 24
$162.8M
$68.0M
Q3 24
$120.0M
$77.0M
Q2 24
$271.6M
$73.0M
Q1 24
$318.0M
$41.0M
Total Debt
COLL
COLL
DTM
DTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$3.4B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
COLL
COLL
DTM
DTM
Q4 25
$301.7M
$4.7B
Q3 25
$274.8M
$4.7B
Q2 25
$232.2M
$4.7B
Q1 25
$234.4M
$4.6B
Q4 24
$228.8M
$4.6B
Q3 24
$234.3M
$4.2B
Q2 24
$216.6M
$4.2B
Q1 24
$222.2M
$4.2B
Total Assets
COLL
COLL
DTM
DTM
Q4 25
$1.7B
$10.1B
Q3 25
$1.6B
$10.1B
Q2 25
$1.6B
$10.0B
Q1 25
$1.6B
$9.9B
Q4 24
$1.7B
$9.9B
Q3 24
$1.6B
$8.6B
Q2 24
$1.1B
$9.0B
Q1 24
$1.1B
$9.0B
Debt / Equity
COLL
COLL
DTM
DTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.72×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
DTM
DTM
Operating Cash FlowLast quarter
$123.0M
$161.0M
Free Cash FlowOCF − Capex
$122.4M
$30.0M
FCF MarginFCF / Revenue
59.6%
9.5%
Capex IntensityCapex / Revenue
0.3%
41.3%
Cash ConversionOCF / Net Profit
7.25×
1.45×
TTM Free Cash FlowTrailing 4 quarters
$327.6M
$441.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
DTM
DTM
Q4 25
$123.0M
$161.0M
Q3 25
$78.4M
$274.0M
Q2 25
$72.4M
$185.0M
Q1 25
$55.4M
$247.0M
Q4 24
$84.6M
$152.0M
Q3 24
$-9.0M
$205.0M
Q2 24
$67.4M
$165.0M
Q1 24
$61.9M
$241.0M
Free Cash Flow
COLL
COLL
DTM
DTM
Q4 25
$122.4M
$30.0M
Q3 25
$78.3M
$131.0M
Q2 25
$72.4M
$104.0M
Q1 25
$54.6M
$176.0M
Q4 24
$84.1M
$62.0M
Q3 24
$-9.2M
$124.0M
Q2 24
$67.1M
$84.0M
Q1 24
$61.4M
$143.0M
FCF Margin
COLL
COLL
DTM
DTM
Q4 25
59.6%
9.5%
Q3 25
37.4%
41.7%
Q2 25
38.5%
33.7%
Q1 25
30.7%
58.1%
Q4 24
46.2%
24.9%
Q3 24
-5.8%
50.0%
Q2 24
46.2%
34.4%
Q1 24
42.3%
59.6%
Capex Intensity
COLL
COLL
DTM
DTM
Q4 25
0.3%
41.3%
Q3 25
0.1%
45.5%
Q2 25
0.0%
26.2%
Q1 25
0.4%
23.4%
Q4 24
0.3%
36.1%
Q3 24
0.2%
32.7%
Q2 24
0.2%
33.2%
Q1 24
0.4%
40.8%
Cash Conversion
COLL
COLL
DTM
DTM
Q4 25
7.25×
1.45×
Q3 25
2.49×
2.38×
Q2 25
6.05×
1.73×
Q1 25
22.92×
2.29×
Q4 24
6.75×
2.08×
Q3 24
-0.96×
2.33×
Q2 24
3.44×
1.72×
Q1 24
2.23×
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

DTM
DTM

Pipeline Segment$173.0M55%
Gathering Segment$144.0M45%

Related Comparisons